CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE | A204100 | MACLEODS PHARMACEUTICALS LTD
Highest NADAC/Unit
$1.14
per ea
Lowest NADAC/Unit
$0.9736
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 33342013310CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB | $1.14 | EA | Generic | — | 2026-06-17 |
| 33342013315CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB | $1.14 | EA | Generic | — | 2026-06-17 |
| 33342013210CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB | $1.06 | EA | Generic | — | 2026-06-17 |
| 33342013215CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB | $1.06 | EA | Generic | — | 2026-06-17 |
| 33342013110CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB | $0.9736 | EA | Generic | — | 2026-06-17 |
| 33342013115CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB | $0.9736 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.